| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 07/20/2011 | CN101829075B Applications of kukoamine A and kukoamine B |
| 07/20/2011 | CN101816668B Medical application of 2-O-alpha-L-rhamnose-4,6,4'-trihydroxybenzophenone |
| 07/20/2011 | CN101797325B Medicament composition for treating gynecologic inflammation and preparation method and application thereof |
| 07/20/2011 | CN101721672B Medicine for treating rheumatic numbness and pain |
| 07/20/2011 | CN101693073B Compound caesalpinia pulcherrima spraying agent and preparation method thereof |
| 07/20/2011 | CN101670035B Preparation method of Chinese medicinal composition for treating cancerous pain |
| 07/20/2011 | CN101664397B Application of high-purity EPA-E and DHA polyenoic acid ethyl ester in preparation of nutritional supplement for patients in operative period |
| 07/20/2011 | CN101628067B Medicament for treating diskal hernia and arthralgia |
| 07/20/2011 | CN101531721B Industrial preparation method for triterpenoid saponin monomer |
| 07/20/2011 | CN101406548B Chinese medicine preparation for treating arthromeningitis and preparation technique |
| 07/20/2011 | CN101361980B Heparin phospholipid composite suitable for non-injection administration and preparation method thereof |
| 07/20/2011 | CN101346144B Therapeutic uses of steroidal compounds |
| 07/20/2011 | CN101317893B Xuebijing oral administration effervescing agent |
| 07/20/2011 | CN101297942B Itch-reliving detumescence agent containing plant vinegar liquid and preparation thereof |
| 07/20/2011 | CN101293030B Medicine liqueur for treating muscles and bones diseases |
| 07/20/2011 | CN101292975B Application of paclitaxel and its derivative in pharmacy |
| 07/20/2011 | CN101287454B Iontophoresis preparation for treatment of breast cancer and/or mastitis |
| 07/20/2011 | CN101269138B Traditional Chinese medicine for treating hemorrhoid |
| 07/20/2011 | CN101264188B Orally-administered medicinal liquor for treating rheumatic arthritis and preparation thereof |
| 07/20/2011 | CN101248077B P38 map kinase inhibitors and methods for using the same |
| 07/20/2011 | CN101234147B Method of preparing total flavones of tropaeolum for injections |
| 07/20/2011 | CN101084911B Notoginsenoside sodium freezing-dried emulsion and preparation method thereof |
| 07/20/2011 | CN101073595B Glycyrrhiza total flavonoid and total saponin extract and its production |
| 07/19/2011 | US7982037 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3 |
| 07/19/2011 | US7981906 (2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl-benzofuran-2-carboxamide, novel salt forms, and methods of use thereof |
| 07/19/2011 | US7981900 2-phenyl pyrimidines which are tubulin inhibitors |
| 07/19/2011 | US7981894 Polymorphic forms of 1-′4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 07/19/2011 | US7981660 Methods for producing modified glycoproteins |
| 07/19/2011 | US7981631 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment and monitoring of periodontal diseases |
| 07/19/2011 | US7981448 Method of treating necrotizing enterocolitis in a patient, which includes administering a pharmaceutical composition that includes carbon monoxide to the patient. |
| 07/19/2011 | US7981420 Therapeutic use of antibodies directed against repulsive guidance molecule (RGM) |
| 07/19/2011 | US7981413 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
| 07/19/2011 | CA2485677C Methods of treating allergic reactions |
| 07/19/2011 | CA2485503C Phenyl-thiophene type vitamin d receptor modulators |
| 07/19/2011 | CA2475818C Aryl ureas as kinase inhibitors |
| 07/19/2011 | CA2473218C Disease susceptibility gene for rheumatoid arthritis, protein thereof, evaluation method and evaluation kit for evaluating onset possibility of rheumatoid arthritis by using those, and remedy and curing medicine for rheumatoid arthritis |
| 07/19/2011 | CA2472713C N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
| 07/19/2011 | CA2448561C Aminoquinoline derivatives and their use as adenosine a3 ligands |
| 07/19/2011 | CA2431606C Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
| 07/19/2011 | CA2291740C Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 07/14/2011 | WO2011085103A2 Plasma kallikrein binding proteins |
| 07/14/2011 | WO2011085033A2 Dp2 antagonist and uses thereof |
| 07/14/2011 | WO2011084571A2 Azide derivatives for phototherapy |
| 07/14/2011 | WO2011084513A2 Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers |
| 07/14/2011 | WO2011084366A2 Methods, compositions and drug delivery systems for intraocular delivery of sirna molecules |
| 07/14/2011 | WO2011083487A1 Sulfone compounds as 5-ht6 receptor ligands |
| 07/14/2011 | WO2011083291A1 Combinations comprising an ant i -inflammatory agent and/or an antibacterial agent and a glycosylamine and their use in medicine |
| 07/14/2011 | WO2011083124A1 Flt3 receptor antagonists for the treatment or the prevention of pain disorders |
| 07/14/2011 | WO2011082951A1 Combination preparations comprising a cytokine antagonist and corticosteroid |
| 07/14/2011 | US20110173707 System for the Determination of Molecules Altering the Function of Interferon, Method Therefor and Compounds Altering Interferon Activity |
| 07/14/2011 | US20110172434 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments |
| 07/14/2011 | US20110172292 Antidote oligomers |
| 07/14/2011 | US20110172285 Proteasome inhibitors |
| 07/14/2011 | US20110172264 Nicotinic acetylcholine receptor modulators |
| 07/14/2011 | US20110172263 Indole derivatives as crth2 receptor antagonists |
| 07/14/2011 | US20110172261 DIBENZO[f,h]ISOQUINOLINE DERIVATIVES |
| 07/14/2011 | US20110172253 Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines |
| 07/14/2011 | US20110172246 1-(2-phenoxymethylphenyl)piperazine compounds |
| 07/14/2011 | US20110172235 Substituted triazolophthalazine derivatives |
| 07/14/2011 | US20110172231 2,4- diaminopyrimidine derivatives |
| 07/14/2011 | US20110172228 Kinase inhibitors and methods of use |
| 07/14/2011 | US20110172217 Ring-fused morpholine derivative having pi3k-inhibiting activity |
| 07/14/2011 | US20110172216 Pyrazolopyrimidine pi3k inhibitor compounds and methods of use |
| 07/14/2011 | US20110172213 Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer |
| 07/14/2011 | US20110172212 Amine-based compound and use thereof |
| 07/14/2011 | US20110172209 3h-imidazo[4,5-b]pyridin-5-ol derivatives useful in the treatment of gpr81 receptor disorders |
| 07/14/2011 | US20110172198 TGR5 Modulators And Methods Of Use Thereof |
| 07/14/2011 | US20110172189 Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use |
| 07/14/2011 | US20110172186 Inhibitors of fatty acid amide hydrolase |
| 07/14/2011 | US20110172182 Carboxyethylated Cyclodextrin Polysulfates Useful As Medicaments |
| 07/14/2011 | US20110172160 Heat-stable, aqueous lactoferrin composition and its preparation and use |
| 07/14/2011 | US20110172159 Proteic acid polymer, production processes, use of proteic acid polymer, pharmaceutical composition and method of treatment |
| 07/14/2011 | US20110172157 Somatostatin analogues |
| 07/14/2011 | US20110172155 Beta thymosin fragments |
| 07/14/2011 | US20110172140 Poly-Pegylated Protease Inhibitors |
| 07/14/2011 | US20110172114 Compositions and methods for the treatment of immune related diseases |
| 07/14/2011 | US20110171330 Anti-fever botanical composition and uses thereof |
| 07/14/2011 | US20110171325 Systems and Methods for Treating Pain Using Brain Stimulation |
| 07/14/2011 | US20110171307 Methods and products for treatment of diseases |
| 07/14/2011 | US20110171285 Design of Fibrinogen and Fibrinogen Derived Products with Reduced Bacterial Binding by Using Modified Sequences of Fibrinogen Chains |
| 07/14/2011 | US20110171275 Gastroretentive drug delivery system, preparation method and use thereof |
| 07/14/2011 | US20110171272 Urological medical devices for release of prostatically beneficial therapeutic agents |
| 07/14/2011 | US20110171265 Composition Comprising Parasite Eggs and Methods for Isolation and Storage of Parasite Eggs |
| 07/14/2011 | US20110171242 Ligand for herpes simplex virus entry mediator and methods of use |
| 07/14/2011 | US20110171220 Pd-1 specific antibodies and uses thereof |
| 07/14/2011 | US20110171218 Compositions and methods for increasing serum half-life |
| 07/14/2011 | US20110171217 Stable liquid antibody formulation |
| 07/14/2011 | US20110171212 Methods and compositions for preventing radiation-induced pneumonitis |
| 07/14/2011 | US20110171200 Protein c rs2069915 as a response predictor to survival and administration of activated protein c or protein c-like compound |
| 07/14/2011 | US20110171192 Substituted amine derivative and medicinal composition comprising same as the active ingredient |
| 07/14/2011 | US20110171187 Dietary supplements for promotion of growth, repair, and maintenance of bone and joints |
| 07/14/2011 | US20110171178 Compositions and methods of using proislet peptides and analogs thereof |
| 07/14/2011 | US20110171172 Compounds for inhibiting ksp kinesin activity |
| 07/14/2011 | US20110171171 Bridged secondary amines and use thereof as iap bir domain binding compounds |
| 07/14/2011 | US20110171163 Polymer conjugates of ziconotide peptides |
| 07/14/2011 | US20110171140 Absorption of therapeutic agents across mucosal membranes or the skin |
| 07/14/2011 | US20110171130 A3 adenosine receptor antagonists and partial agonists |
| 07/14/2011 | CA2786072A1 Sulfone compounds as 5-ht6 receptor ligands |
| 07/14/2011 | CA2786019A1 Plasma kallikrein binding proteins |
| 07/14/2011 | CA2782085A1 Dp2 antagonist and uses thereof |